In patients with colorectal cancer, accurate assessment of tumour extent within and beyond the bowel wall and detection of lymph node and distant metastases are of paramount importance in planning the surgical approach, in deciding whether neo-adjuvant chemotherapy or radiation therapy is necessary, and in determining the risk of tumour recurrence and overall prognosis. The utility of MDCT, MR, transrectal ultrasound, PET, PET/CT is discussed and recommendations for cost-effective imaging in these patients are presented.

*Reprinted from Cancer Imaging (2005) 5, 99--102, http://www.cancerimaging.org, doi: 10.1102/1470-7330.2005.0021. Corresponds to presentation titled `Staging colorectal cancer: MDCT, MR, TRUS, or PET/CT'.

Author

Richard M Gore

Contact Details

Corresponding address:
Richard M Gore, MD,
Gastrointestinal Imaging,
Department of Diagnostic Radiology,
Evanston Northwestern Healthcare,
Northwestern University,
2650 Ridge Avenue, Evanston,
IL 60201, USA

Reference

ICIS Cancer Imaging Volume 5 Special Issue A
DOI: 10.1102/1470-7330.2005.0021

Date Posted

24 November 2005

Screen PDF

Size

470.57 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	1 second
ADSL 512Kb/s (Broadband):	7 seconds
64 Kb/s (ISDN):	58 seconds
33.3 Kb/s (Typical Modem):	1 minute 53 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.